- Singapore is the country of choice for our commercialization center and investment fund. Singapore has proven efficiency and cost-effectiveness in the distribution and implementation of healthcare services. Singapore is leading the way forward to a smart health nation.
- More than 60 multinational MedTech companies in Singapore are undertaking a wide range of activities, from product innovation to manufacturing, research, and development.
- The availability of government initiatives, designed to enhance the healthcare sectors with technologies, like robotics, (AI), the industrial internet-of-things (IoT), and cloud computing, are encouraging factors to house our Center here.
- Over SGD$4 billion in public sector research funding is allocated in developing health and biomedical sciences for the next five years.
Connect with us to learn more